U.S. flag

An official website of the United States government

NM_000138.5(FBN1):c.2855-139dup AND not provided

Germline classification:
Benign (1 submission)
Last evaluated:
Jun 1, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000590824.1

Allele description [Variation Report for NM_000138.5(FBN1):c.2855-139dup]

NM_000138.5(FBN1):c.2855-139dup

Gene:
FBN1:fibrillin 1 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
15q21.1
Genomic location:
Preferred name:
NM_000138.5(FBN1):c.2855-139dup
HGVS:
  • NC_000015.10:g.48490224dup
  • NG_008805.2:g.160572dup
  • NM_000138.5:c.2855-139dupMANE SELECT
  • LRG_778:g.160572dup
  • NC_000015.9:g.48782421dup
  • NM_000138.4:c.2855-139dupT
Links:
dbSNP: rs200982490
NCBI 1000 Genomes Browser:
rs200982490
Molecular consequence:
  • NM_000138.5:c.2855-139dup - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000695494Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Benign
(Jun 1, 2017)
germlineclinical testing

LabCorp Variant Classification Summary - May 2015.docx

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000695494.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: The FBN1 c.2855-139dupT variant involves the alteration of an intronic nucleotide and 4/5 splice prediction tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. This variant was found in the large, broad control population, gnomAD that includes ExAC data and additional whole exome and genome sequences with an allele frequency of 29/30704 (1 homozygote) control chromosomes, predominantly observed in the European (Non-Finnish) subpopulation at a frequency of 0.001479 (22/14872 including 1 homozygote). This frequency is about 13 times the estimated maximal expected allele frequency of a pathogenic FBN1 variant (0.0001125), suggesting this is likely a benign polymorphism found primarily in population(s) of European (Non-Finnish) origin. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 5, 2022